Officer/Director Files Intent to Sell $304K in Shares, Continuing Recent Distribution Trend
summarizeSummary
An Officer and Director of Kestra Medical Technologies has filed to sell $304K worth of shares, extending a recent trend of insider selling totaling over $1.4 million in the last three months.
check_boxKey Events
-
Officer/Director Files Intent to Sell Shares
Brian Webster, an Officer and Director, filed a Form 144 to sell 15,000 common shares.
-
Significant Proposed Sale Value
The proposed sale is valued at approximately $304,123.49.
-
Continuation of Recent Selling Trend
This filing extends a pattern of insider selling, with Webster having sold an additional 45,000 shares for $1.12 million in the past three months, bringing total recent dispositions to over $1.4 million.
-
Shares from Equity Compensation
The shares intended for sale were recently acquired on January 21, 2026, as part of an issuer equity compensation plan.
auto_awesomeAnalysis
Brian Webster, an Officer and Director, has filed a Form 144 indicating intent to sell 15,000 common shares valued at approximately $304,123. This proposed sale follows a pattern of significant share dispositions by Webster, who has already sold 45,000 shares totaling over $1.1 million in the past three months. The shares intended for sale were recently acquired through a restricted share issuance as part of an equity compensation plan. This ongoing selling activity by a key insider, especially following recent disclosures of material weaknesses in internal controls, could signal a lack of conviction or a desire for liquidity, potentially creating an overhang on the stock.
At the time of this filing, KMTS was trading at $19.27 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.2B. The 52-week trading range was $13.25 to $30.00. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.